Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics
2011

Understanding Heterogeneity in Meta-Analysis

Sample size: 18 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jack Bowden, Jayne F Tierney, Andrew J Copas, Sarah Burdett

Primary Institution: MRC Clinical Trials Unit

Hypothesis

Can the generalised Q statistic provide a better estimate of heterogeneity in meta-analyses compared to the standard Q statistic?

Conclusion

Using the generalised Q statistic offers a more accurate method for estimating heterogeneity in meta-analyses than the standard Q statistic.

Supporting Evidence

  • The generalised Q statistic provided a more accurate estimate of heterogeneity than the standard Q statistic.
  • Significant heterogeneity was found in the meta-analyses, particularly in NSCLC 4 and Cervix 1.
  • The study recommends incorporating generalised Q statistic methods into statistical software.

Takeaway

This study looks at how to better understand differences in results from medical studies by using a new way to measure those differences, which helps researchers make better decisions.

Methodology

The study reviews 18 individual patient data meta-analyses of randomized controlled trials (RCTs) focusing on cancer treatments to assess heterogeneity using both standard and generalised Q statistics.

Potential Biases

Potential bias due to small study effects and publication bias.

Limitations

The study may not account for all sources of heterogeneity and relies on the quality of the included trials.

Participant Demographics

The meta-analyses included trials primarily focused on cancer treatments.

Statistical Information

P-Value

0.005

Confidence Interval

95% CI for NSCLC 4: (0.61-1.16)

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2288-11-41

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication